Joey L. Methot - Concepedia

Concepedia

Author

Joey L. Methot

Merck & Co., Inc., Rahway, NJ, USA (United States)ORCID

Also Known As

BindingDB, Joey L Methot, Joey L. Methot, Joey Methot, Joey L. Methot, Methot, Joey L.

49

Publications

1.8K

Citations

17

H-Index

38

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Quantitative BioSciences University of Michigan

JL

About

Joey L. Methot is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, medicine, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	513
2	Natural Sciences	11	11	1.4K
3	Biochemistry	10	10	1.3K
4	Biomolecular Engineering	2	2	996
5	Engineering	1	1	965

Joey L. Methot

×

25

Publications

1.8K

Citations

17

H-Index

	Year	Citations
Nucleophilic Phosphine Organocatalysis Joey L. Methot, William Roush Advanced Synthesis & Catalysis Asymmetric CatalysisNovel OrganocatalystsEngineeringBiochemistryNatural Sciences	2004	965
Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2) Joey L. Methot, Prasun K. Chakravarty, Mélissa Chénard, Bioorganic & Medicinal Chemistry Letters Histone ModificationsChromatinMedicinal ChemistrySelective Hdac1/hdac2 InhibitorsBiochemistry	2007	185
Synthetic Studies toward FR182877. Remarkable Solvent Effect in the Vinylogous Morita−Baylis−Hillman Cyclization Joey L. Methot, William Roush Organic Letters	2003	78
Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds Brandon Vara, Samuel M. Levi, Abdelghani Achab, ACS Medicinal Chemistry Letters	2021	47
Molecular and Biologic Analysis of Histone Deacetylase Inhibitors with Diverse Specificities Andrea Newbold, Geoffrey M. Matthews, Michael Bots, Molecular Cancer Therapeutics Histone ModificationsChemoprevention StrategyEpigenetic ChangeMolecular BiologyEpigenetics	2013	46
SAR profiles of spirocyclic nicotinamide derived selective HDAC1/HDAC2 inhibitors (SHI-1:2) Joey L. Methot, Christopher L. Hamblett, Dawn M. Mampreian, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryPharmaceutical ScienceSar ProfilesBiochemistryMedicine	2008	44
The discovery of 6-amino nicotinamides as potent and selective histone deacetylase inhibitors Christopher L. Hamblett, Joey L. Methot, Dawn M. Mampreian, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryMedicineNatural SciencesRational Drug Design	2007	43
Identification of Potent Reverse Indazole Inhibitors for HPK1 Elsie C. Yu, Joey L. Methot, Xavier Fradera, ACS Medicinal Chemistry Letters	2021	35
Pharmacological inhibition of hematopoietic progenitor kinase 1 positively regulates T-cell function Yun Wang, Kelvin Zhang, Peter Georgiev, PLoS ONE	2020	33
Delayed and Prolonged Histone Hyperacetylation with a Selective HDAC1/HDAC2 Inhibitor Joey L. Methot, Dawn Mampreian Hoffman, David J. Witter, ACS Medicinal Chemistry Letters Histone ModificationsEpigenetic ChangeMolecular BiologyCell CulturePharmacotherapy	2014	31

Page 1